Literature DB >> 26855300

Serological Survey for Antibodies to Mosquito-Borne Bunyaviruses Among US National Park Service and US Forest Service Employees.

Olga Kosoy1, Ingrid Rabe1, Aimee Geissler2, Jennifer Adjemian2, Amanda Panella1, Janeen Laven1, Alison J Basile1, Jason Velez1, Kevin Griffith1, David Wong3, Marc Fischer1, Robert S Lanciotti1.   

Abstract

Serum samples from 295 employees of Great Smoky Mountains National Park (GRSM), Rocky Mountain National Park (ROMO), and Grand Teton National Park with adjacent Bridger-Teton National Forest (GRTE-BTNF) were subjected to serological analysis for mosquito-borne bunyaviruses. The sera were analyzed for neutralizing antibodies against six orthobunyaviruses: La Crosse virus (LACV), Jamestown Canyon virus (JCV), snowshoe hare virus (SSHV), California encephalitis virus, and Trivittatus virus (TVTV) belonging to the California serogroup and Cache Valley virus (CVV) belonging to the Bunyamwera serogroup. Sera were also tested for immunoglobulin (Ig) G antibodies against LACV and JCV by enzyme-linked immunosorbent assay (ELISA). The proportion of employees with neutralizing antibodies to any California serogroup bunyavirus was similar in all three sites, with the prevalence ranging from 28% to 36%. The study demonstrated a seroprevalence of 3% to CVV across the three parks. However, proportions of persons with antibodies to specific viruses differed between parks. Participants residing in the eastern regions had a higher seroprevalence to LACV, with 24% (18/75) GRSM employees being seropositive. In contrast, SSHV seroprevalence was limited to employees from the western sites, with 1.7% (1/60) ROMO and 3.8% (6/160) GRTE-BTNF employees being positive. Seroprevalence to JCV was noted in employees from all sites at rates of 6.7% in GRSM, 21.7% in ROMO, and 15.6% in GRTE-BTNF. One employee each from ROMO (1.7%) and GRTE-BTNF (1.9%) were positive for TVTV. This study also has illustrated the greater sensitivity and specificity of plaque reduction neutralization test compared to IgG ELISA in conducting serosurveys for LACV and JCV.

Entities:  

Keywords:  Antibodies; Arbovirus(es); Bunyaviruses; Mosquito(es); Vector borne

Mesh:

Substances:

Year:  2016        PMID: 26855300     DOI: 10.1089/vbz.2015.1865

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  10 in total

1.  Francisella tularensis Exposure Among National Park Service Employees During an Epizootic: Devils Tower National Monument, Wyoming, 2015.

Authors:  Alexia Harrist; Cara Cherry; Natalie Kwit; Katie Bryan; Ryan Pappert; Jeannine Petersen; Danielle Buttke; David Wong; Christina Nelson
Journal:  Vector Borne Zoonotic Dis       Date:  2018-12-01       Impact factor: 2.133

2.  A novel cause of chronic viral meningoencephalitis: Cache Valley virus.

Authors:  Michael R Wilson; Dan Suan; Andrew Duggins; Ryan D Schubert; Lillian M Khan; Hannah A Sample; Kelsey C Zorn; Aline Rodrigues Hoffman; Anna Blick; Meena Shingde; Joseph L DeRisi
Journal:  Ann Neurol       Date:  2017-07       Impact factor: 10.422

3.  Culex tarsalis is a competent vector species for Cache Valley virus.

Authors:  Victoria B Ayers; Yan-Jang S Huang; Amy C Lyons; So Lee Park; Stephen Higgs; James I Dunlop; Alain Kohl; Barry W Alto; Isik Unlu; Bradley J Blitvich; Dana L Vanlandingham
Journal:  Parasit Vectors       Date:  2018-09-20       Impact factor: 3.876

4.  Differences in Neuropathogenesis of Encephalitic California Serogroup Viruses.

Authors:  Alyssa B Evans; Clayton W Winkler; Karin E Peterson
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

5.  Enhanced Arboviral Surveillance to Increase Detection of Jamestown Canyon Virus Infections, Wisconsin, 2011-2016.

Authors:  Eduard Matkovic; Diep K Hoang Johnson; J Erin Staples; Maria C Mora-Pinzon; Lina I Elbadawi; Rebecca A Osborn; David M Warshauer; Mark V Wegner; Jeffrey P Davis
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

Review 6.  Cache Valley virus: A scoping review of the global evidence.

Authors:  Lisa Waddell; Nicole Pachal; Mariola Mascarenhas; Judy Greig; Shannon Harding; Ian Young; Barbara Wilhelm
Journal:  Zoonoses Public Health       Date:  2019-06-28       Impact factor: 2.702

7.  Monoclonal antibodies to Cache Valley virus for serological diagnosis.

Authors:  Benjamin Skinner; Sierra Mikula; Brent S Davis; Jordan A Powers; Holly R Hughes; Amanda E Calvert
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

8.  Screening for Viral Nucleic Acids in the Cerebrospinal Fluid of Dogs With Central Nervous System Inflammation.

Authors:  Renee M Barber; Qiang Li; Jonathan M Levine; Susan J Ruone; Gwendolyn J Levine; Patrick Kenny; Suxiang Tong; Scott J Schatzberg
Journal:  Front Vet Sci       Date:  2022-03-24

9.  Risk factors associated with seropositivity to California serogroup viruses in humans and pet dogs, Quebec, Canada.

Authors:  J P Rocheleau; P Michel; L R Lindsay; M Drebot; A Dibernardo; N H Ogden; A Fortin; J Arsenault
Journal:  Epidemiol Infect       Date:  2018-05-02       Impact factor: 4.434

Review 10.  Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.

Authors:  Alyssa B Evans; Karin E Peterson
Journal:  Viruses       Date:  2019-08-29       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.